Nurix Therapeutics Overview
Nurix Therapeutics Target Price
Analysts' 12-month price predictions for NRIX.
Share Price
$9.91
Average Target Price
$23.00
132.1% upside
132.1% upside2 analysts in the last 4 months
High: $30 | Low: $16
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-07-15 | Morgan StanleyTerence Flynn | $16 | 61.5% upside |  |
| 2025-07-10 | OppenheimerMatthew Biegler | $30 | 202.7% upside | |
| 2025-03-17 | Leerink Partners | $16 | 61.5% upside | |
| 2025-02-03 | Morgan StanleyTerence Flynn | $17 | 71.5% upside | |
| 2024-12-05 | BMO CapitalEtzer Darout | $35 | 253.2% upside | |
| 2024-10-24 | UBSDavid Dai | $35 | 253.2% upside | |
| 2024-10-21 | H.C. WainwrightRobert Burns | $30 | 202.7% upside | |
| 2024-10-15 | OppenheimerMatthew Biegler | $35 | 253.2% upside | |
| 2024-10-15 | Wells FargoDerek Archila | $32 | 222.9% upside | |
| 2024-10-14 | Stifel NicolausStephen Willey | $34 | 243.1% upside | |
| 2024-10-11 | JefferiesRoger Song | $41 | 313.7% upside | |
| 2024-09-05 | Robert W. BairdBrian Skorney | $26 | 162.4% upside | |
| 2024-08-14 | OppenheimerMatthew Biegler | $27 | 172.5% upside | |
| 2024-06-27 | RBC CapitalGregory Renza | $26 | 162.4% upside | |
| 2024-06-18 | H.C. WainwrightRobert Burns | $26 | 162.4% upside | |
| 2024-06-05 | Piper SandlerTyler Van Buren | $35 | 253.2% upside | |
| 2024-04-11 | RBC CapitalGregory Renza | $23 | 132.1% upside | |
| 2024-04-11 | Robert W. BairdJoel Beatty | $25 | 152.3% upside | |
| 2022-12-13 | Leerink Partners | $28 | 182.5% upside | |
| 2022-05-31 | Wells FargoDerek Archila | $25 | 152.3% upside | |